{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T16:19:32Z","timestamp":1788452372917,"version":"build-2803163510"},"reference-count":70,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T00:00:00Z","timestamp":1775520000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004440","name":"Wellcome","doi-asserted-by":"publisher","award":["217173\/Z\/19\/Z"],"award-info":[{"award-number":["217173\/Z\/19\/Z"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome","doi-asserted-by":"publisher","award":["310879\/Z\/24\/Z"],"award-info":[{"award-number":["310879\/Z\/24\/Z"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000921","name":"European Cooperation in Science and Technology","doi-asserted-by":"publisher","award":["CA21111"],"award-info":[{"award-number":["CA21111"]}],"id":[{"id":"10.13039\/501100000921","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal for Parasitology: Drugs and Drug Resistance"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.ijpddr.2026.100641","type":"journal-article","created":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T08:24:40Z","timestamp":1775809480000},"page":"100641","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Screening of purine nucleoside analogues against intracellular Toxoplasma gondii"],"prefix":"10.1016","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9339-6002","authenticated-orcid":false,"given":"Hamza A.A.","family":"Elati","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serge","family":"Van Calenbergh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lilach","family":"Sheiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9963-1827","authenticated-orcid":false,"given":"Harry P.","family":"de Koning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpddr.2026.100641_bib1","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.bcp.2010.06.001","article-title":"Carbocyclic 6-benzylthioinosine analogues as subversive substrates of Toxoplasma gondii adenosine kinase: biological activities and selective toxicities","volume":"80","author":"Al Safarjalani","year":"2010","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ijpddr.2026.100641_bib2","doi-asserted-by":"crossref","first-page":"273","DOI":"10.2147\/DDDT.S60973","article-title":"Drugs in development for toxoplasmosis: advances, challenges, and current status","volume":"11","author":"Alday","year":"2017","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.ijpddr.2026.100641_bib3","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27228045","article-title":"The Trypanosoma cruzi TcrNT2 nucleoside transporter is a conduit for the uptake of 5-F-2\u2032-Deoxyuridine and tubercidin analogues","volume":"27","author":"Aldfer","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.ijpddr.2026.100641_bib4","doi-asserted-by":"crossref","first-page":"8139","DOI":"10.3390\/ijms23158139","article-title":"Nucleoside transport and nucleobase uptake null mutants in Leishmania mexicana for the routine expression and characterization of purine and pyrimidine transporters","volume":"23","author":"Aldfer","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijpddr.2026.100641_bib5","article-title":"Pyrimidine biosynthesis is not an essential function for Trypanosoma brucei bloodstream forms","volume":"8","author":"Ali","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ijpddr.2026.100641_bib6","doi-asserted-by":"crossref","first-page":"4206","DOI":"10.1021\/acs.jmedchem.1c00135","article-title":"Revisiting Pyrazolo[3,4-]pyrimidine nucleosides as anti-Trypanosoma cruzi and antileishmanial agents","volume":"64","author":"Bouton","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ijpddr.2026.100641_bib7","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1038\/nrneurol.2016.149","article-title":"HIV-associated opportunistic CNS infections: pathophysiology, diagnosis and treatment","volume":"12","author":"Bowen","year":"2016","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.ijpddr.2026.100641_bib8","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1002\/med.21667","article-title":"Purine and pyrimidine transporters of pathogenic protozoa - conduits for therapeutic agents","volume":"40","author":"Campagnaro","year":"2020","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.ijpddr.2026.100641_bib9","doi-asserted-by":"crossref","first-page":"710","DOI":"10.3390\/ijms23020710","article-title":"A Toxoplasma gondii oxopurine transporter binds nucleobases and nucleosides using different binding modes","volume":"23","author":"Campagnaro","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijpddr.2026.100641_bib10","doi-asserted-by":"crossref","first-page":"31221","DOI":"10.1074\/jbc.M404232200","article-title":"Purine salvage pathways in the apicomplexan parasite Toxoplasma gondii","volume":"279","author":"Chaudhary","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijpddr.2026.100641_bib11","doi-asserted-by":"crossref","first-page":"35255","DOI":"10.1074\/jbc.274.49.35255","article-title":"The adenosine transporter of Toxoplasma gondii. Identification by insertional mutagenesis, cloning, and recombinant expression","volume":"274","author":"Chiang","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijpddr.2026.100641_bib12","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3390\/ph11020043","article-title":"Evaluation of anti-effect of ursolic acid as a novel toxoplasmosis inhibitor","volume":"11","author":"Choi","year":"2018","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.ijpddr.2026.100641_bib13","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/S0020-7519(03)00091-2","article-title":"Identification and characterisation of high affinity nucleoside and nucleobase transporters in Toxoplasma gondii","volume":"33","author":"De Koning","year":"2003","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.ijpddr.2026.100641_bib14","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1111\/j.1432-1033.1997.01102.x","article-title":"Hypoxanthine uptake through a purine\u2010selective nucleobase transporter in Trypanosoma brucei brucei procyclic cells is driven by protonmotive force","volume":"247","author":"De Koning","year":"1997","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.ijpddr.2026.100641_bib15","first-page":"1162","article-title":"Adenosine transporters in bloodstream forms of Trypanosoma brucei brucei: substrate recognition motifs and affinity for trypanocidal drugs","volume":"56","author":"De Koning","year":"1999","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ijpddr.2026.100641_bib16","doi-asserted-by":"crossref","first-page":"46596","DOI":"10.1074\/jbc.M309320200","article-title":"The adenosine analog tubercidin inhibits glycolysis in as revealed by an RNA interference library","volume":"278","author":"Drew","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijpddr.2026.100641_bib17","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/S0020-7519(98)00023-X","article-title":"Advances in the life cycle of Toxoplasma gondii","volume":"28","author":"Dubey","year":"1998","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.ijpddr.2026.100641_bib18","doi-asserted-by":"crossref","DOI":"10.1128\/CMR.00057-17","article-title":"Treatment of toxoplasmosis: historical perspective, animal models, and current clinical practice","volume":"31","author":"Dunay","year":"2018","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.ijpddr.2026.100641_bib19","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1016\/S0140-6736(98)08220-8","article-title":"Mother-to-child transmission of toxoplasmosis: risk estimates for clinical counselling","volume":"353","author":"Dunn","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.ijpddr.2026.100641_bib20","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1128\/AAC.43.10.2437","article-title":"Metabolism and selective toxicity of 6-nitrobenzylthioinosine in Toxoplasma gondii","volume":"43","author":"El Kouni","year":"1999","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2026.100641_bib21","doi-asserted-by":"crossref","first-page":"266","DOI":"10.3390\/pathogens15030266","article-title":"Identification of TgENT1 as the TgUUT1 uracil\/uridine transporter of Toxoplasma gondii","volume":"15","author":"Elati","year":"2026","journal-title":"Pathogens"},{"key":"10.1016\/j.ijpddr.2026.100641_bib22","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2023.1320160","article-title":"Pyrimidine salvage in Toxoplasma gondii as a target for new treatment","volume":"13","author":"Elati","year":"2023","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.ijpddr.2026.100641_bib23","article-title":"Epidemiology, pathophysiology, diagnosis, and management of cerebral toxoplasmosis","volume":"34","author":"Elsheikha","year":"2021","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.ijpddr.2026.100641_bib24","doi-asserted-by":"crossref","first-page":"8087","DOI":"10.3390\/molecules27228087","article-title":"Phenotypic evaluation of nucleoside analogues against Trypanosoma cruzi infection: in vitro and in vivo approaches","volume":"27","author":"Fiuza","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.ijpddr.2026.100641_bib25","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1124\/mol.104.010298","article-title":"Molecular pharmacology of adenosine transport in Trypanosoma brucei: P1\/P2 revisited","volume":"68","author":"Geiser","year":"2005","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ijpddr.2026.100641_bib26","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1051\/parasite\/2000071039","article-title":"Toxoplasma encephalitis: influence of the vehicle on the efficacy of different doses of 2',3'-dideoxyinosine in mice","volume":"7","author":"Gherardi","year":"2000","journal-title":"Parasite"},{"key":"10.1016\/j.ijpddr.2026.100641_bib27","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0304-4157(96)00008-1","article-title":"Nucleoside and nucleobase transport systems of mammalian cells","volume":"1286","author":"Griffith","year":"1996","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ijpddr.2026.100641_bib28","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1021\/acsinfecdis.0c00105","article-title":"Structure-activity relationship exploration of 3\u2032-Deoxy-7-deazapurine nucleoside analogues as anti-Trypanosoma brucei agents","volume":"6","author":"Hulpia","year":"2020","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.ijpddr.2026.100641_bib29","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.ejmech.2018.12.050","article-title":"Revisiting tubercidin against kinetoplastid parasites: aromatic substitutions at position 7 improve activity and reduce toxicity","volume":"164","author":"Hulpia","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ijpddr.2026.100641_bib30","doi-asserted-by":"crossref","first-page":"5564","DOI":"10.1038\/s41467-019-13522-6","article-title":"Combining tubercidin and cordycepin scaffolds results in highly active candidates to treat late-stage sleeping sickness","volume":"10","author":"Hulpia","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ijpddr.2026.100641_bib31","doi-asserted-by":"crossref","first-page":"9287","DOI":"10.1021\/acs.jmedchem.8b00999","article-title":"Discovery of novel 7-Aryl 7-Deazapurine 3\u2032-Deoxy-ribofuranosyl nucleosides with potent activity against Trypanosoma cruzi","volume":"61","author":"Hulpia","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ijpddr.2026.100641_bib32","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1021\/acsinfecdis.4c00472","article-title":"Discovery and development of an advanced lead for the treatment of African trypanosomiasis","volume":"11","author":"Ilbeigi","year":"2025","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.ijpddr.2026.100641_bib33","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1016\/0006-2952(95)00029-Y","article-title":"Structure-activity relationship for the binding of nucleoside ligands to adenosine kinase from Toxoplasma gondii","volume":"49","author":"Iltzsch","year":"1995","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ijpddr.2026.100641_bib34","first-page":"1013","article-title":"Genetic analysis of nucleoside transport in Leishmania donovani","volume":"4","author":"Iovannisci","year":"1984","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.ijpddr.2026.100641_bib35","doi-asserted-by":"crossref","first-page":"231","DOI":"10.3389\/fphar.2014.00231","article-title":"How drugs get into cells: tested and testable predictions to help discriminate between transporter-mediated uptake and lipoidal bilayer diffusion","volume":"5","author":"Kell","year":"2014","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ijpddr.2026.100641_bib36","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.parint.2018.07.004","article-title":"Congenital toxoplasmosis: an overview of the neurological and ocular manifestations","volume":"67","author":"Khan","year":"2018","journal-title":"Parasitol. Int."},{"key":"10.1016\/j.ijpddr.2026.100641_bib37","doi-asserted-by":"crossref","first-page":"3403","DOI":"10.1016\/j.bmc.2010.04.003","article-title":"Structure-activity relationships of carbocyclic 6-benzylthioinosine analogues as subversive substrates of adenosine kinase","volume":"18","author":"Kim","year":"2010","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ijpddr.2026.100641_bib38","doi-asserted-by":"crossref","first-page":"10601","DOI":"10.1016\/S0021-9258(18)81663-5","article-title":"Purine metabolism in Toxoplasma gondii","volume":"264","author":"Krug","year":"1989","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijpddr.2026.100641_bib39","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1128\/EC.3.2.245-254.2004","article-title":"Nucleoside and nucleobase transporters in parasitic protozoa","volume":"3","author":"Landfear","year":"2004","journal-title":"Eukaryot. Cell"},{"key":"10.1016\/j.ijpddr.2026.100641_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114165","article-title":"N6-modification of 7-Deazapurine nucleoside analogues as Anti-Trypanosoma cruzi and anti-leishmania agents: structure-Activity relationship exploration and in vivo evaluation","volume":"231","author":"Lin","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ijpddr.2026.100641_bib41","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ijpddr.2021.08.001","article-title":"6-Methyl-7-deazapurine nucleoside analogues as broad-spectrum antikinetoplastid agents","volume":"17","author":"Lin","year":"2021","journal-title":"Int. J. Parasitol. Drugs Drug Resist."},{"key":"10.1016\/j.ijpddr.2026.100641_bib42","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1093\/clinids\/15.2.211","article-title":"Toxoplasmic encephalitis in AIDS","volume":"15","author":"Luft","year":"1992","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ijpddr.2026.100641_bib43","doi-asserted-by":"crossref","first-page":"555","DOI":"10.2174\/138161207780162809","article-title":"Chemotherapeutic strategies against Trypanosoma brucei: drug targets vs. drug targeting","volume":"13","author":"Luscher","year":"2007","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.ijpddr.2026.100641_bib44","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ijpddr.2022.05.001","article-title":"Nucleoside analogues for the treatment of animal trypanosomiasis","volume":"19","author":"Mabille","year":"2022","journal-title":"Int. J. Parasitol. Drugs Drug Resist."},{"key":"10.1016\/j.ijpddr.2026.100641_bib45","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.02207-25","article-title":"Impact of equilibrative nucleoside transporters on Toxoplasma gondii infection and differentiation","volume":"16","author":"Messina","year":"2025","journal-title":"mBio"},{"key":"10.1016\/j.ijpddr.2026.100641_bib46","first-page":"898","article-title":"Global status of Toxoplasma gondii infection: systematic review and prevalence snapshots","volume":"36","author":"Molan","year":"2019","journal-title":"Trop. Biomed."},{"key":"10.1016\/j.ijpddr.2026.100641_bib47","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1016\/S0140-6736(04)16412-X","article-title":"Toxoplasmosis","volume":"363","author":"Montoya","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.ijpddr.2026.100641_bib48","doi-asserted-by":"crossref","first-page":"32","DOI":"10.3389\/fphar.2015.00032","article-title":"Transport proteins determine drug sensitivity and resistance in a protozoan parasite, Trypanosoma brucei","volume":"6","author":"Munday","year":"2015","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ijpddr.2026.100641_bib49","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1111\/mmi.14840","article-title":"Comprehensive characterization of purine and pyrimidine transport activities in Trichomonas vaginalis and functional cloning of a trichomonad nucleoside transporter","volume":"116","author":"Natto","year":"2021","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.ijpddr.2026.100641_bib50","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1006\/expr.2000.4519","article-title":"Toxoplasma gondii: are host cell adenosine nucleotides a direct source for purine salvage?","volume":"95","author":"Ngo","year":"2000","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.ijpddr.2026.100641_bib51","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/0014-4894(91)90109-A","article-title":"Leishmania donovani: characteristics of adenosine and inosine transporters in promastigotes of two different strains","volume":"73","author":"Ogbunude","year":"1991","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.ijpddr.2026.100641_bib52","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1111\/j.1550-7408.1971.tb03356.x","article-title":"Incorporation of precursors into toxoplasma DNA","volume":"18","author":"Perrotto","year":"1971","journal-title":"J. Protozool."},{"key":"10.1016\/j.ijpddr.2026.100641_bib53","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1006\/expr.2001.4673","article-title":"Toxoplasma gondii: mechanism of the parasitostatic action of 6-thioxanthine","volume":"99","author":"Pfefferkorn","year":"2001","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.ijpddr.2026.100641_bib54","doi-asserted-by":"crossref","first-page":"993","DOI":"10.2307\/3279197","article-title":"Arabinosyl nucleosides inhibit Toxoplasma gondii and allow the selection of resistant mutants","volume":"62","author":"Pfefferkorn","year":"1976","journal-title":"J. Parasitol."},{"key":"10.1016\/j.ijpddr.2026.100641_bib55","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1186\/s13071-025-07054-w","article-title":"A nucleoside transporter on the mitochondria of is essential for maintaining normal growth of the parasite","volume":"18","author":"Qian","year":"2025","journal-title":"Parasites Vectors"},{"key":"10.1016\/j.ijpddr.2026.100641_bib56","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.2307\/3284647","article-title":"Alterations of Toxoplasma gondii induced by 2',3'-dideoxyinosine in vitro","volume":"84","author":"Sarciron","year":"1998","journal-title":"J. Parasitol."},{"key":"10.1016\/j.ijpddr.2026.100641_bib57","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1128\/AAC.41.7.1531","article-title":"Effects of 2',3'-dideoxyinosine on Toxoplasma gondii cysts in mice","volume":"41","author":"Sarciron","year":"1997","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2026.100641_bib58","first-page":"301","article-title":"Adenosine kinase from normal mouse erythrocytes and from Plasmodium chabaudi: partial purification and characterization","volume":"25","author":"Schmidt","year":"1974","journal-title":"Tropenmed. Parasitol."},{"key":"10.1016\/j.ijpddr.2026.100641_bib59","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0014-4894(82)90094-7","article-title":"Toxoplasma gondii: purine synthesis and salvage in mutant host cells and parasites","volume":"53","author":"Schwartzman","year":"1982","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.ijpddr.2026.100641_bib60","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002392","article-title":"A systematic screen to discover and analyze apicoplast proteins identifies a conserved and essential protein import factor","volume":"7","author":"Sheiner","year":"2011","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.ijpddr.2026.100641_bib61","doi-asserted-by":"crossref","first-page":"35127","DOI":"10.1074\/jbc.M306188200","article-title":"Equilibrative nucleoside transporter family members from Leishmania donovani are electrogenic proton symporters","volume":"278","author":"Stein","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijpddr.2026.100641_bib62","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1126\/science.1078035","article-title":"Recent expansion of through enhanced oral transmission","volume":"299","author":"Su","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.ijpddr.2026.100641_bib63","doi-asserted-by":"crossref","DOI":"10.3389\/fpara.2025.1634209","article-title":"Guanine derivatives as promising candidates for the development of purine-based antimalarial drugs","volume":"4","author":"Tashie","year":"2025","journal-title":"Front. Parasitol."},{"key":"10.1016\/j.ijpddr.2026.100641_bib64","doi-asserted-by":"crossref","first-page":"3144","DOI":"10.3390\/ijms24043144","article-title":"Cloning and characterization of Trypanosoma congolense and T. vivax nucleoside transporters reveal the potential of P1-Type carriers for the discovery of broad-spectrum nucleoside-based therapeutics against animal African trypanosomiasis","volume":"24","author":"Ungogo","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijpddr.2026.100641_bib65","doi-asserted-by":"crossref","first-page":"9873","DOI":"10.1073\/pnas.95.17.9873","article-title":"Cloning of Leishmania nucleoside transporter genes by rescue of a transport-deficient mutant","volume":"95","author":"Vasudevan","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"24","key":"10.1016\/j.ijpddr.2026.100641_bib66","doi-asserted-by":"crossref","first-page":"9861","DOI":"10.1021\/jm401530a","article-title":"Structure\u2013activity relationships of synthetic cordycepin analogues as experimental therapeutics for African trypanosomiasis","volume":"56","author":"Vodnala","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ijpddr.2026.100641_bib67","doi-asserted-by":"crossref","first-page":"26149","DOI":"10.1074\/jbc.M202835200","article-title":"Different substrate recognition motifs of human and trypanosome nucleobase transporters. Selective uptake of purine antimetabolites","volume":"277","author":"Wallace","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijpddr.2026.100641_bib68","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/j.ijantimicag.2019.08.023","article-title":"Efficacy of antiretroviral compounds against Toxoplasma gondii in vitro","volume":"54","author":"Wang","year":"2019","journal-title":"Int. J. Antimicrob. Agents"},{"issue":"5010","key":"10.1016\/j.ijpddr.2026.100641_bib69","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1126\/science.1925539","article-title":"Atomic structure of adenosine deaminase complexed with a transition-state analog: understanding catalysis and immunodeficiency mutations","volume":"252","author":"Wilson","year":"1991","journal-title":"Science"},{"key":"10.1016\/j.ijpddr.2026.100641_bib70","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1080\/14760584.2023.2157818","article-title":"Insight into the current Toxoplasma gondii DNA vaccine: a review article","volume":"22","author":"Zhang","year":"2023","journal-title":"Expert Rev. Vaccines"}],"container-title":["International Journal for Parasitology: Drugs and Drug Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211320726000114?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211320726000114?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T15:42:34Z","timestamp":1788450154000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211320726000114"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":70,"alternative-id":["S2211320726000114"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpddr.2026.100641","relation":{"has-preprint":[{"id-type":"doi","id":"10.64898\/2026.02.11.705309","asserted-by":"object"}]},"ISSN":["2211-3207"],"issn-type":[{"value":"2211-3207","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Screening of purine nucleoside analogues against intracellular Toxoplasma gondii","name":"articletitle","label":"Article Title"},{"value":"International Journal for Parasitology: Drugs and Drug Resistance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpddr.2026.100641","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd on behalf of Australian Society for Parasitology.","name":"copyright","label":"Copyright"}],"article-number":"100641"}}